Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2004British Journal of Haematology

von Willebrand factor cleaving protease (ADAMTS‐13) and ADAMTS‐13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura

View Full Paper
Ask AI
Bookmark
Share

Authors

FPFlora PeyvandiBroad InstituteSFSilvia FerrariBaxter (Austria)SLSilvia LavoretanoUniversity of Milan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Peyvandi et al. (2004) studied this question.

synapsesocial.com/papers/6a96e2c10f79e4f014b31143https://doi.org/10.1111/j.1365-2141.2004.05217.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1von Willebrand factor cleaving protease and ADAMTS13mutations in childhood TTP2003 · 218 citations
  2. 2von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome2002 · 192 citations
  3. 3Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic Purpura1982 · 1,118 citations
  4. 4Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura1991 · 1,940 citations